GENITAL CHLAMYDIA-TRACHOMATIS INFECTIONS IN PATIENTS WITH CERVICAL ATYPIA

Abstract

Of 177 gynecologic outpatients with cervical dysplasia studied, 29 (16%) excreted C. trachomatis from their urogenital tract. Sera collected from 93 of these patients were significantly more often positive for and showed higher levels of antichlamydial microcomplement fixation (CF) and immunofluorescence (IF) antibodies than sera obtained from the controls. When the sera were tested for anti-herpesvirus type II (HSV-II) and cytomegalovirus (CMV) antibodies, no difference between the cases and the controls were encountered.